BriaCell Therapeutics (BCTX) Return on Equity [ROE] (2021 - 2026)
BriaCell Therapeutics (BCTX) posted Return on Equity [ROE] of -115.53% for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 143.44 percentage points from -258.98% a year earlier and up 35.94 percentage points from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025 (ended Jul 31, 2025), BriaCell Therapeutics' Return on Equity [ROE] came in at -362.56%.
- Annual Return on Equity [ROE] shows a four-year change of -359.13 percentage points (FY2021 to FY2025).
- In prior fiscal years, BriaCell Therapeutics' Return on Equity [ROE] was -619.75% in FY2023 (-540.00 pp), -79.75% in FY2022 (-76.32 pp) and -3.44% in FY2021.
- The fiscal Q3 2026 figure stands as the highest quarterly Return on Equity [ROE] since fiscal Q3 2022.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -151.47% (Q2 2026), -217.39% (Q1 2026) and -181.42% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | BriaCell Therapeutics | 29.29 Mn | 28.64 Mn | - | -115.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -115.53% |
| Jan 31, 2026 | -151.47% |
| Oct 31, 2025 | -217.39% |
| Jul 31, 2025 | -181.42% |
| Apr 30, 2025 | -258.98% |
| Jan 31, 2025 | -337.86% |
| Oct 31, 2024 | -3,252.60% |
| Jan 31, 2023 | -507.62% |
| Oct 31, 2022 | -144.83% |
| Jul 31, 2022 | -159.07% |
| Apr 30, 2022 | -103.89% |
| Jan 31, 2022 | -65.70% |
| Oct 31, 2021 | -15.63% |
API Access
BriaCell Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();